Angioimmunoblastic T-cell lymphoma epidemiology and demographics

Angioimmunoblastic T-cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Biopsy
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Angioimmunoblastic T-cell lymphoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Angioimmunoblastic T-cell lymphoma epidemiology and demographics
CDC on Angioimmunoblastic T-cell lymphoma epidemiology and demographics
Angioimmunoblastic T-cell lymphoma epidemiology and demographics in the news
Blogs on Angioimmunoblastic T-cell lymphoma epidemiology and demographics
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [3]

Overview

AILT comprises 15-20% of peripheral T-cell lymphomas and 1-2% of all non-Hodgkin lymphomas.

Age

The typical patient with angioimmunoblastic T-cell lymphoma (AILT) is either middle-aged or elderly.

Gender

No gender preference for this disease has been observed.